Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

San Antonio, Texas

Phase 1 cancer trials in San Antonio, TX

118 Phase 1 cancer studies are recruiting participants at sites in San Antonio as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

San Antonio at a glance

Breast cancer studies recruiting in San Antonio

Basic details from each study's public record (the 30 most recently updated of 118). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    EMD Serono Research & Development Institute, Inc.
    Study site
    NEXT Oncology - PARENT
    Registry record
    NCT07360314 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    START San Antonio (STSA)
    Registry record
    NCT07488676 · updated
  3. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study site
    UT Health San Antonio's Mays Cancer Center
    Registry record
    NCT06270706 · updated
  4. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Study sites
    START San Antonio, LLC · University of Texas Health Science Center San Antonio
    Registry record
    NCT06638307 · updated
  5. A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    South Texas Accelerated Research Therapeutics (START), LLC
    Registry record
    NCT06827236 · updated
  6. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study sites
    NEXT Texas LLC - San Antonio · START San Antonio, LLC
    Registry record
    NCT07503808 · updated
  7. Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer

    • Phase 1
    • Ages 18 and older
    • Female participants
    Sponsor
    Immunomic Therapeutics, Inc.
    Study site
    START San Antonio
    Registry record
    NCT07652242 · updated
  8. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    South Texas Accelerated Research Therapeutics (START) San Antonio
    Registry record
    NCT07029399 · updated
  9. A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    START San Antonio
    Registry record
    NCT07318805 · updated
  10. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    South Texas Accelerated Research Therapeutics (START)
    Registry record
    NCT06465069 · updated
  11. Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    The University of Texas Health Science Center at San Antonio
    Study site
    Mays Cancer Center, UT Health San Antonio
    Registry record
    NCT07137871 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in San Antonio, TX on ClinicalTrials.gov.

Lung cancer studies recruiting in San Antonio

  1. Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Vivace Therapeutics, Inc
    Study site
    NEXT Oncology
    Registry record
    NCT04665206 · updated
  2. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    START San Antonio
    Registry record
    NCT05786924 · updated
  3. A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    EpiBiologics
    Study site
    Site 102 - START San Antonio
    Registry record
    NCT07462377 · updated
  4. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Tyligand Pharmaceuticals (Suzhou) Limited
    Study site
    NEXT Oncology
    Registry record
    NCT06385925 · updated
  5. A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    START San Antonio, LLC
    Registry record
    NCT07903415 · updated
  6. A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    NEXT Oncology
    Registry record
    NCT03460977 · updated
  7. A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Bayer
    Study site
    START | San Antonio
    Registry record
    NCT06914128 · updated
  8. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    START- San Antonio
    Registry record
    NCT07080242 · updated
  9. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Study site
    NEXT Oncology
    Registry record
    NCT07458347 · updated
  10. A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    NEXT Oncology
    Registry record
    NCT07090499 · updated
  11. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    NEXT Oncology
    Registry record
    NCT07397338 · updated
  12. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    NEXT Oncology
    Registry record
    NCT06720987 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in San Antonio, TX on ClinicalTrials.gov.

Prostate cancer studies recruiting in San Antonio

  1. JUR-003 in Adult Patients With Metastatic Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Juri Biosciences, Inc.
    Study site
    START San Antonio
    Registry record
    NCT07824349 · updated
  2. A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    South Texas Accelerated Research Therapeutics, LLC (START)
    Registry record
    NCT06095089 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in San Antonio, TX on ClinicalTrials.gov.

Lymphoma studies recruiting in San Antonio

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study sites
    Children's Hospital of San Antonio · Methodist Children's Hospital of South Texas · University of Texas Health Science Center at San Antonio
    Registry record
    NCT04726241 · updated
  2. A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Debiopharm International SA
    Study site
    South Texas Accelerated Research Therapeutics (START)
    Registry record
    NCT05765812 · updated
  3. A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment

    • Phase 1
    • Ages 18 to 80
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    Texas Liver Institute - American Research Corporation
    Registry record
    NCT07853040 · updated
  4. A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

    • Phase 1
    • Ages 0 to 18
    • All sexes
    Sponsor
    Autolus Limited
    Study site
    Methodist Children's Hospital
    Registry record
    NCT06173518 · updated
  5. TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

    • Phase 1/2
    • Up to age 1
    • All sexes
    Sponsor
    Tanja Andrea Gruber
    Study site
    University of Texas Health Science Center San Antonio
    Registry record
    NCT05848687 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in San Antonio, TX on ClinicalTrials.gov.

Ask about studies near San Antonio

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Texas

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call